Top 10 Life Science Consulting Companies in Europe - 2023
The life sciences consulting market in Europe is subject to many influential factors that affect the demand for consulting services. According to a recent article by the European Pharmaceutical Review, the life sciences industry in Europe is expected to face significant regulatory changes in 2023. These changes span five key areas, including clinical trials, medical devices, pharmaceutical legislation, class actions, and the regulation of artificial intelligence (AI). In addition, the potential introduction of class action mechanisms and AI regulation initiatives highlights the changing landscape in the European life sciences sector.
One of the most important factors is the regulatory environment that governs the life sciences industry, with changes in regulations related to drug approvals, clinical trials, and data privacy necessitating consulting support for navigating complex compliance frameworks. Economic factors such as GDP growth, inflation rates, and government healthcare spending significantly impact businesses' willingness to invest in consulting services.
This edition of Life Sciences Review features life sciences consulting services providers in Europe that have emerged as the forerunners in the industry despite the market challenges and roadblocks. It covers Fuliginous Management Consulting a management consulting firm that provides consulting services to the pharmaceutical contract manufacturing industry. The firm offers services to both CDMOs and pharmaceutical companies cooperating with CDMOs. The company’s objective is to help clients identify the issues hindering their progress and design appropriate strategies in the future, requiring deep and integrated market knowledge and an unbiased and objective view.
It also includes the valuable perspectives of Dr Linda Randall, AVP, Biologics Development, Manufacturing & Control at Pharmaron [SHE: 300759], and Xavier Salas, Corporate Legal & Compliance Manager at Neuraxpharm. They share their views on the current state of the life sciences consulting industry in Europe, its challenges, and its prospects.










